Martine Rothblatt
2011
In 2011, Martine Rothblatt earned a total compensation of $3.2M as Chief Executive Officer at United Therapeutics, a 82% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $1,409,730 |
|---|---|
| Non-Equity Incentive Plan | $804,960 |
| Salary | $931,485 |
| Other | $15,175 |
| Total | $3,161,350 |
Rothblatt received $1.4M of change in pension value and nonqualified deferred compensation earnings, accounting for 45% of the total pay in 2011.
Rothblatt also received $805K in non-equity incentive plan, $931.5K in salary and $15.2K in other compensation.
Rankings
In 2011, Martine Rothblatt's compensation ranked 2,004th out of 10,747 executives tracked by ExecPay. In other words, Rothblatt earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,004 out of 10,747 | 81st |
Division Manufacturing | 723 out of 3,960 | 82nd |
Major group Chemicals And Allied Products | 155 out of 1,033 | 85th |
Industry group Drugs | 88 out of 781 | 89th |
Industry Pharmaceutical Preparations | 74 out of 571 | 87th |
Source: SEC filing on April 30, 2014.
Rothblatt's colleagues
We found three more compensation records of executives who worked with Martine Rothblatt at United Therapeutics in 2011.